miR‐106b‐5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3 Article Swipe
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1002/cam4.2511
Background and Objectives The roles of microRNA(miR)‐106b‐5p in hepatocellular carcinoma (HCC) remain unclear. We aimed here to investigate the clinical significance of miR‐106b‐5p expression in HCC and its underlying mechanisms. Methods Expression levels of miR‐106b‐5p in 108 HCC clinical samples by quantitative real‐time reverse transcription PCR. Associations of miR‐106b‐5p expression with various clinicopathological features and patients' prognosis were evaluated by Chi‐square test, Kaplan‐Meier, and Cox proportional regression analyses, respectively. The target gene of miR‐106b‐5p and their functions in HCC cells were investigated by luciferase reporter, CCK‐8, and Transwell Matrigel invasion assays. Results miR‐106b‐5p expression was markedly higher in HCC tissues than in noncancerous adjacent liver tissues ( P < .001). miR‐106b‐5p upregulation was significantly associated with advanced TNM stage ( P = .02), short recurrence‐free ( P = .005), and overall ( P = .001) survivals. Importantly, miR‐106b‐5p expression was an independent predictor of poor prognosis ( P < .05). RUNX3 was identified as a direct target gene of miR‐106b‐5p in HCC cells. Functionally, miR‐106b‐5p upregulation promoted the viability and invasion of HCC cells, while enforced RUNX3 expression reversed the oncogenic effects of miR‐106b‐5p overexpression. Conclusions miR‐106b‐5p may serve as a potent prognostic marker for tumor recurrence and survival of HCC patients. miR‐106b‐5p may exert an oncogenic role in HCC via regulating its target gene RUNX3.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1002/cam4.2511
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.2511
- OA Status
- gold
- Cited By
- 39
- References
- 31
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2972782324
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2972782324Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1002/cam4.2511Digital Object Identifier
- Title
-
miR‐106b‐5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2019Year of publication
- Publication date
-
2019-09-10Full publication date if available
- Authors
-
Hao Gu, Shensen Gu, Xinlong Zhang, Song-Jiang Zhang, Dongming Zhang, Jun Lin, Saiken Hasengbayi, Wei HanList of authors in order
- Landing page
-
https://doi.org/10.1002/cam4.2511Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.2511Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.2511Direct OA link when available
- Concepts
-
Hepatocellular carcinoma, Downregulation and upregulation, Matrigel, microRNA, Cancer research, Medicine, Reporter gene, Proportional hazards model, Gene expression, Internal medicine, Oncology, Gene, Biology, Angiogenesis, BiochemistryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
39Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 5, 2024: 5, 2023: 2, 2022: 4, 2021: 13Per-year citation counts (last 5 years)
- References (count)
-
31Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2972782324 |
|---|---|
| doi | https://doi.org/10.1002/cam4.2511 |
| ids.doi | https://doi.org/10.1002/cam4.2511 |
| ids.mag | 2972782324 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/31503422 |
| ids.openalex | https://openalex.org/W2972782324 |
| fwci | 2.43609742 |
| mesh[0].qualifier_ui | Q000235 |
| mesh[0].descriptor_ui | D014408 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | genetics |
| mesh[0].descriptor_name | Biomarkers, Tumor |
| mesh[1].qualifier_ui | Q000235 |
| mesh[1].descriptor_ui | D006528 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | genetics |
| mesh[1].descriptor_name | Carcinoma, Hepatocellular |
| mesh[2].qualifier_ui | Q000473 |
| mesh[2].descriptor_ui | D006528 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | pathology |
| mesh[2].descriptor_name | Carcinoma, Hepatocellular |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D045744 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Cell Line, Tumor |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D049109 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Cell Proliferation |
| mesh[5].qualifier_ui | Q000235 |
| mesh[5].descriptor_ui | D050677 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | genetics |
| mesh[5].descriptor_name | Core Binding Factor Alpha 3 Subunit |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D018450 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Disease Progression |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D005260 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Female |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D015972 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Gene Expression Regulation, Neoplastic |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D056945 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Hep G2 Cells |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D006801 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Humans |
| mesh[11].qualifier_ui | Q000235 |
| mesh[11].descriptor_ui | D008113 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | genetics |
| mesh[11].descriptor_name | Liver Neoplasms |
| mesh[12].qualifier_ui | Q000473 |
| mesh[12].descriptor_ui | D008113 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | pathology |
| mesh[12].descriptor_name | Liver Neoplasms |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D008297 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Male |
| mesh[14].qualifier_ui | Q000235 |
| mesh[14].descriptor_ui | D035683 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | genetics |
| mesh[14].descriptor_name | MicroRNAs |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D009367 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Neoplasm Staging |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D011379 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Prognosis |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D016019 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Survival Analysis |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D015854 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Up-Regulation |
| mesh[19].qualifier_ui | Q000235 |
| mesh[19].descriptor_ui | D014408 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | genetics |
| mesh[19].descriptor_name | Biomarkers, Tumor |
| mesh[20].qualifier_ui | Q000235 |
| mesh[20].descriptor_ui | D006528 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | genetics |
| mesh[20].descriptor_name | Carcinoma, Hepatocellular |
| mesh[21].qualifier_ui | Q000473 |
| mesh[21].descriptor_ui | D006528 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | pathology |
| mesh[21].descriptor_name | Carcinoma, Hepatocellular |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D045744 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Cell Line, Tumor |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D049109 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Cell Proliferation |
| mesh[24].qualifier_ui | Q000235 |
| mesh[24].descriptor_ui | D050677 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | genetics |
| mesh[24].descriptor_name | Core Binding Factor Alpha 3 Subunit |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D018450 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Disease Progression |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D005260 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Female |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D015972 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Gene Expression Regulation, Neoplastic |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D056945 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Hep G2 Cells |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D006801 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Humans |
| mesh[30].qualifier_ui | Q000235 |
| mesh[30].descriptor_ui | D008113 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | genetics |
| mesh[30].descriptor_name | Liver Neoplasms |
| mesh[31].qualifier_ui | Q000473 |
| mesh[31].descriptor_ui | D008113 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | pathology |
| mesh[31].descriptor_name | Liver Neoplasms |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D008297 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Male |
| mesh[33].qualifier_ui | Q000235 |
| mesh[33].descriptor_ui | D035683 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | genetics |
| mesh[33].descriptor_name | MicroRNAs |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D009367 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Neoplasm Staging |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D011379 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Prognosis |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D016019 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Survival Analysis |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D015854 |
| mesh[37].is_major_topic | True |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Up-Regulation |
| type | article |
| title | miR‐106b‐5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3 |
| biblio.issue | 15 |
| biblio.volume | 8 |
| biblio.last_page | 6767 |
| biblio.first_page | 6756 |
| topics[0].id | https://openalex.org/T10062 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1306 |
| topics[0].subfield.display_name | Cancer Research |
| topics[0].display_name | MicroRNA in disease regulation |
| topics[1].id | https://openalex.org/T10515 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9998999834060669 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1306 |
| topics[1].subfield.display_name | Cancer Research |
| topics[1].display_name | Cancer-related molecular mechanisms research |
| topics[2].id | https://openalex.org/T11765 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9998999834060669 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Circular RNAs in diseases |
| is_xpac | False |
| apc_list.value | 2300 |
| apc_list.currency | EUR |
| apc_list.value_usd | 3025 |
| apc_paid.value | 2300 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 3025 |
| concepts[0].id | https://openalex.org/C2778019345 |
| concepts[0].level | 2 |
| concepts[0].score | 0.8335896134376526 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1148337 |
| concepts[0].display_name | Hepatocellular carcinoma |
| concepts[1].id | https://openalex.org/C127561419 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7731810808181763 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q224527 |
| concepts[1].display_name | Downregulation and upregulation |
| concepts[2].id | https://openalex.org/C2778608917 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6897773742675781 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q6787805 |
| concepts[2].display_name | Matrigel |
| concepts[3].id | https://openalex.org/C145059251 |
| concepts[3].level | 3 |
| concepts[3].score | 0.673296332359314 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q310899 |
| concepts[3].display_name | microRNA |
| concepts[4].id | https://openalex.org/C502942594 |
| concepts[4].level | 1 |
| concepts[4].score | 0.6177126169204712 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[4].display_name | Cancer research |
| concepts[5].id | https://openalex.org/C71924100 |
| concepts[5].level | 0 |
| concepts[5].score | 0.47052016854286194 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[5].display_name | Medicine |
| concepts[6].id | https://openalex.org/C161733203 |
| concepts[6].level | 4 |
| concepts[6].score | 0.44741952419281006 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q911828 |
| concepts[6].display_name | Reporter gene |
| concepts[7].id | https://openalex.org/C50382708 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4470753073692322 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q223218 |
| concepts[7].display_name | Proportional hazards model |
| concepts[8].id | https://openalex.org/C150194340 |
| concepts[8].level | 3 |
| concepts[8].score | 0.3944282829761505 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q26972 |
| concepts[8].display_name | Gene expression |
| concepts[9].id | https://openalex.org/C126322002 |
| concepts[9].level | 1 |
| concepts[9].score | 0.3926265239715576 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[9].display_name | Internal medicine |
| concepts[10].id | https://openalex.org/C143998085 |
| concepts[10].level | 1 |
| concepts[10].score | 0.3843439817428589 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[10].display_name | Oncology |
| concepts[11].id | https://openalex.org/C104317684 |
| concepts[11].level | 2 |
| concepts[11].score | 0.37803298234939575 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[11].display_name | Gene |
| concepts[12].id | https://openalex.org/C86803240 |
| concepts[12].level | 0 |
| concepts[12].score | 0.3557945787906647 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[12].display_name | Biology |
| concepts[13].id | https://openalex.org/C2780394083 |
| concepts[13].level | 2 |
| concepts[13].score | 0.11712515354156494 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q539568 |
| concepts[13].display_name | Angiogenesis |
| concepts[14].id | https://openalex.org/C55493867 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[14].display_name | Biochemistry |
| keywords[0].id | https://openalex.org/keywords/hepatocellular-carcinoma |
| keywords[0].score | 0.8335896134376526 |
| keywords[0].display_name | Hepatocellular carcinoma |
| keywords[1].id | https://openalex.org/keywords/downregulation-and-upregulation |
| keywords[1].score | 0.7731810808181763 |
| keywords[1].display_name | Downregulation and upregulation |
| keywords[2].id | https://openalex.org/keywords/matrigel |
| keywords[2].score | 0.6897773742675781 |
| keywords[2].display_name | Matrigel |
| keywords[3].id | https://openalex.org/keywords/microrna |
| keywords[3].score | 0.673296332359314 |
| keywords[3].display_name | microRNA |
| keywords[4].id | https://openalex.org/keywords/cancer-research |
| keywords[4].score | 0.6177126169204712 |
| keywords[4].display_name | Cancer research |
| keywords[5].id | https://openalex.org/keywords/medicine |
| keywords[5].score | 0.47052016854286194 |
| keywords[5].display_name | Medicine |
| keywords[6].id | https://openalex.org/keywords/reporter-gene |
| keywords[6].score | 0.44741952419281006 |
| keywords[6].display_name | Reporter gene |
| keywords[7].id | https://openalex.org/keywords/proportional-hazards-model |
| keywords[7].score | 0.4470753073692322 |
| keywords[7].display_name | Proportional hazards model |
| keywords[8].id | https://openalex.org/keywords/gene-expression |
| keywords[8].score | 0.3944282829761505 |
| keywords[8].display_name | Gene expression |
| keywords[9].id | https://openalex.org/keywords/internal-medicine |
| keywords[9].score | 0.3926265239715576 |
| keywords[9].display_name | Internal medicine |
| keywords[10].id | https://openalex.org/keywords/oncology |
| keywords[10].score | 0.3843439817428589 |
| keywords[10].display_name | Oncology |
| keywords[11].id | https://openalex.org/keywords/gene |
| keywords[11].score | 0.37803298234939575 |
| keywords[11].display_name | Gene |
| keywords[12].id | https://openalex.org/keywords/biology |
| keywords[12].score | 0.3557945787906647 |
| keywords[12].display_name | Biology |
| keywords[13].id | https://openalex.org/keywords/angiogenesis |
| keywords[13].score | 0.11712515354156494 |
| keywords[13].display_name | Angiogenesis |
| language | en |
| locations[0].id | doi:10.1002/cam4.2511 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2754843627 |
| locations[0].source.issn | 2045-7634 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2045-7634 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Cancer Medicine |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_lineage_names | Wiley |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.2511 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Cancer Medicine |
| locations[0].landing_page_url | https://doi.org/10.1002/cam4.2511 |
| locations[1].id | pmid:31503422 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Cancer medicine |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/31503422 |
| locations[2].id | pmh:oai:doaj.org/article:739b60f8a43141349a5f3a3477ca9749 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | cc-by-sa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Cancer Medicine, Vol 8, Iss 15, Pp 6756-6767 (2019) |
| locations[2].landing_page_url | https://doaj.org/article/739b60f8a43141349a5f3a3477ca9749 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:6825988 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Cancer Med |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6825988 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5100735096 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-1533-695X |
| authorships[0].author.display_name | Hao Gu |
| authorships[0].countries | CN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I154093214 |
| authorships[0].affiliations[0].raw_affiliation_string | Digestive Vascular Surgery Center, Xinjiang Medical University, Xinjiang, China |
| authorships[0].institutions[0].id | https://openalex.org/I154093214 |
| authorships[0].institutions[0].ror | https://ror.org/01p455v08 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I154093214 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | Xinjiang Medical University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Hao Gu |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Digestive Vascular Surgery Center, Xinjiang Medical University, Xinjiang, China |
| authorships[1].author.id | https://openalex.org/A5028162028 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Shensen Gu |
| authorships[1].countries | CN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I154093214 |
| authorships[1].affiliations[0].raw_affiliation_string | Digestive Vascular Surgery Center, Xinjiang Medical University, Xinjiang, China |
| authorships[1].institutions[0].id | https://openalex.org/I154093214 |
| authorships[1].institutions[0].ror | https://ror.org/01p455v08 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I154093214 |
| authorships[1].institutions[0].country_code | CN |
| authorships[1].institutions[0].display_name | Xinjiang Medical University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Shensen Gu |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Digestive Vascular Surgery Center, Xinjiang Medical University, Xinjiang, China |
| authorships[2].author.id | https://openalex.org/A5045481063 |
| authorships[2].author.orcid | https://orcid.org/0009-0004-8040-0553 |
| authorships[2].author.display_name | Xinlong Zhang |
| authorships[2].countries | CN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I154093214 |
| authorships[2].affiliations[0].raw_affiliation_string | Digestive Vascular Surgery Center, Xinjiang Medical University, Xinjiang, China |
| authorships[2].institutions[0].id | https://openalex.org/I154093214 |
| authorships[2].institutions[0].ror | https://ror.org/01p455v08 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I154093214 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | Xinjiang Medical University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Xinlong Zhang |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Digestive Vascular Surgery Center, Xinjiang Medical University, Xinjiang, China |
| authorships[3].author.id | https://openalex.org/A5069542693 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Song-Jiang Zhang |
| authorships[3].countries | CN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I154093214 |
| authorships[3].affiliations[0].raw_affiliation_string | Digestive Vascular Surgery Center, Xinjiang Medical University, Xinjiang, China |
| authorships[3].institutions[0].id | https://openalex.org/I154093214 |
| authorships[3].institutions[0].ror | https://ror.org/01p455v08 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I154093214 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | Xinjiang Medical University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Songjiang Zhang |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Digestive Vascular Surgery Center, Xinjiang Medical University, Xinjiang, China |
| authorships[4].author.id | https://openalex.org/A5100632769 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-2016-8639 |
| authorships[4].author.display_name | Dongming Zhang |
| authorships[4].countries | CN |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I154093214 |
| authorships[4].affiliations[0].raw_affiliation_string | Digestive Vascular Surgery Center, Xinjiang Medical University, Xinjiang, China |
| authorships[4].institutions[0].id | https://openalex.org/I154093214 |
| authorships[4].institutions[0].ror | https://ror.org/01p455v08 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I154093214 |
| authorships[4].institutions[0].country_code | CN |
| authorships[4].institutions[0].display_name | Xinjiang Medical University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Dongming Zhang |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Digestive Vascular Surgery Center, Xinjiang Medical University, Xinjiang, China |
| authorships[5].author.id | https://openalex.org/A5101464543 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-4836-4746 |
| authorships[5].author.display_name | Jun Lin |
| authorships[5].countries | CN |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I154093214 |
| authorships[5].affiliations[0].raw_affiliation_string | Digestive Vascular Surgery Center, Xinjiang Medical University, Xinjiang, China |
| authorships[5].institutions[0].id | https://openalex.org/I154093214 |
| authorships[5].institutions[0].ror | https://ror.org/01p455v08 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I154093214 |
| authorships[5].institutions[0].country_code | CN |
| authorships[5].institutions[0].display_name | Xinjiang Medical University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Junsheng Lin |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Digestive Vascular Surgery Center, Xinjiang Medical University, Xinjiang, China |
| authorships[6].author.id | https://openalex.org/A5051404235 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Saiken Hasengbayi |
| authorships[6].countries | CN |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I154093214 |
| authorships[6].affiliations[0].raw_affiliation_string | Digestive Vascular Surgery Center, Xinjiang Medical University, Xinjiang, China |
| authorships[6].institutions[0].id | https://openalex.org/I154093214 |
| authorships[6].institutions[0].ror | https://ror.org/01p455v08 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I154093214 |
| authorships[6].institutions[0].country_code | CN |
| authorships[6].institutions[0].display_name | Xinjiang Medical University |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Saiken Hasengbayi |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Digestive Vascular Surgery Center, Xinjiang Medical University, Xinjiang, China |
| authorships[7].author.id | https://openalex.org/A5005544676 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-0033-1486 |
| authorships[7].author.display_name | Wei Han |
| authorships[7].countries | CN |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I154093214 |
| authorships[7].affiliations[0].raw_affiliation_string | Digestive Vascular Surgery Center, Xinjiang Medical University, Xinjiang, China |
| authorships[7].institutions[0].id | https://openalex.org/I154093214 |
| authorships[7].institutions[0].ror | https://ror.org/01p455v08 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I154093214 |
| authorships[7].institutions[0].country_code | CN |
| authorships[7].institutions[0].display_name | Xinjiang Medical University |
| authorships[7].author_position | last |
| authorships[7].raw_author_name | Wei Han |
| authorships[7].is_corresponding | True |
| authorships[7].raw_affiliation_strings | Digestive Vascular Surgery Center, Xinjiang Medical University, Xinjiang, China |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.2511 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | miR‐106b‐5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3 |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10062 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1306 |
| primary_topic.subfield.display_name | Cancer Research |
| primary_topic.display_name | MicroRNA in disease regulation |
| related_works | https://openalex.org/W2417429578, https://openalex.org/W3117743803, https://openalex.org/W4397046645, https://openalex.org/W2592007767, https://openalex.org/W582905479, https://openalex.org/W2425414548, https://openalex.org/W2177616800, https://openalex.org/W4252430596, https://openalex.org/W2026862129, https://openalex.org/W1980655880 |
| cited_by_count | 39 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 5 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 5 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 2 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 4 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 13 |
| counts_by_year[5].year | 2020 |
| counts_by_year[5].cited_by_count | 10 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1002/cam4.2511 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2754843627 |
| best_oa_location.source.issn | 2045-7634 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2045-7634 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Cancer Medicine |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_lineage_names | Wiley |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.2511 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Cancer Medicine |
| best_oa_location.landing_page_url | https://doi.org/10.1002/cam4.2511 |
| primary_location.id | doi:10.1002/cam4.2511 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2754843627 |
| primary_location.source.issn | 2045-7634 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2045-7634 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Cancer Medicine |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_lineage_names | Wiley |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.2511 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Cancer Medicine |
| primary_location.landing_page_url | https://doi.org/10.1002/cam4.2511 |
| publication_date | 2019-09-10 |
| publication_year | 2019 |
| referenced_works | https://openalex.org/W2917837889, https://openalex.org/W2153935627, https://openalex.org/W4211105405, https://openalex.org/W144423133, https://openalex.org/W2106085645, https://openalex.org/W2159767268, https://openalex.org/W2117391818, https://openalex.org/W4237654651, https://openalex.org/W1648301895, https://openalex.org/W2588025094, https://openalex.org/W1579277069, https://openalex.org/W2155736145, https://openalex.org/W2159446228, https://openalex.org/W2062290101, https://openalex.org/W2589659966, https://openalex.org/W2771145857, https://openalex.org/W2030857870, https://openalex.org/W2736874721, https://openalex.org/W2790726201, https://openalex.org/W2789307901, https://openalex.org/W1550861967, https://openalex.org/W2790212419, https://openalex.org/W2085331591, https://openalex.org/W2093914407, https://openalex.org/W1996551674, https://openalex.org/W2624111147, https://openalex.org/W2297468917, https://openalex.org/W2788775095, https://openalex.org/W2751076114, https://openalex.org/W2081678293, https://openalex.org/W2111471857 |
| referenced_works_count | 31 |
| abstract_inverted_index.( | 107, 120, 126, 132, 147 |
| abstract_inverted_index.= | 122, 128, 134 |
| abstract_inverted_index.P | 108, 121, 127, 133, 148 |
| abstract_inverted_index.a | 155, 191 |
| abstract_inverted_index.We | 14 |
| abstract_inverted_index.an | 141, 206 |
| abstract_inverted_index.as | 154, 190 |
| abstract_inverted_index.by | 41, 60, 83 |
| abstract_inverted_index.in | 8, 25, 36, 78, 98, 102, 161, 209 |
| abstract_inverted_index.of | 6, 22, 34, 48, 73, 144, 159, 172, 183, 200 |
| abstract_inverted_index.to | 17 |
| abstract_inverted_index.108 | 37 |
| abstract_inverted_index.Cox | 65 |
| abstract_inverted_index.HCC | 26, 38, 79, 99, 162, 173, 201, 210 |
| abstract_inverted_index.TNM | 118 |
| abstract_inverted_index.The | 4, 70 |
| abstract_inverted_index.and | 2, 27, 55, 64, 75, 87, 130, 170, 198 |
| abstract_inverted_index.for | 195 |
| abstract_inverted_index.its | 28, 213 |
| abstract_inverted_index.may | 188, 204 |
| abstract_inverted_index.the | 19, 168, 180 |
| abstract_inverted_index.via | 211 |
| abstract_inverted_index.was | 95, 113, 140, 152 |
| abstract_inverted_index.< | 109, 149 |
| abstract_inverted_index.PCR. | 46 |
| abstract_inverted_index.gene | 72, 158, 215 |
| abstract_inverted_index.here | 16 |
| abstract_inverted_index.poor | 145 |
| abstract_inverted_index.role | 208 |
| abstract_inverted_index.than | 101 |
| abstract_inverted_index.were | 58, 81 |
| abstract_inverted_index.with | 51, 116 |
| abstract_inverted_index.(HCC) | 11 |
| abstract_inverted_index..001) | 135 |
| abstract_inverted_index..02), | 123 |
| abstract_inverted_index..05). | 150 |
| abstract_inverted_index.RUNX3 | 151, 177 |
| abstract_inverted_index.aimed | 15 |
| abstract_inverted_index.cells | 80 |
| abstract_inverted_index.exert | 205 |
| abstract_inverted_index.liver | 105 |
| abstract_inverted_index.roles | 5 |
| abstract_inverted_index.serve | 189 |
| abstract_inverted_index.short | 124 |
| abstract_inverted_index.stage | 119 |
| abstract_inverted_index.test, | 62 |
| abstract_inverted_index.their | 76 |
| abstract_inverted_index.tumor | 196 |
| abstract_inverted_index.while | 175 |
| abstract_inverted_index..001). | 110 |
| abstract_inverted_index..005), | 129 |
| abstract_inverted_index.RUNX3. | 216 |
| abstract_inverted_index.cells, | 174 |
| abstract_inverted_index.cells. | 163 |
| abstract_inverted_index.direct | 156 |
| abstract_inverted_index.higher | 97 |
| abstract_inverted_index.levels | 33 |
| abstract_inverted_index.marker | 194 |
| abstract_inverted_index.potent | 192 |
| abstract_inverted_index.remain | 12 |
| abstract_inverted_index.target | 71, 157, 214 |
| abstract_inverted_index.Methods | 31 |
| abstract_inverted_index.Results | 92 |
| abstract_inverted_index.assays. | 91 |
| abstract_inverted_index.effects | 182 |
| abstract_inverted_index.overall | 131 |
| abstract_inverted_index.reverse | 44 |
| abstract_inverted_index.samples | 40 |
| abstract_inverted_index.tissues | 100, 106 |
| abstract_inverted_index.various | 52 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.CCK‐8, | 86 |
| abstract_inverted_index.Matrigel | 89 |
| abstract_inverted_index.adjacent | 104 |
| abstract_inverted_index.advanced | 117 |
| abstract_inverted_index.clinical | 20, 39 |
| abstract_inverted_index.enforced | 176 |
| abstract_inverted_index.features | 54 |
| abstract_inverted_index.invasion | 90, 171 |
| abstract_inverted_index.markedly | 96 |
| abstract_inverted_index.promoted | 167 |
| abstract_inverted_index.reversed | 179 |
| abstract_inverted_index.survival | 199 |
| abstract_inverted_index.unclear. | 13 |
| abstract_inverted_index.Transwell | 88 |
| abstract_inverted_index.analyses, | 68 |
| abstract_inverted_index.carcinoma | 10 |
| abstract_inverted_index.evaluated | 59 |
| abstract_inverted_index.functions | 77 |
| abstract_inverted_index.oncogenic | 181, 207 |
| abstract_inverted_index.patients' | 56 |
| abstract_inverted_index.patients. | 202 |
| abstract_inverted_index.predictor | 143 |
| abstract_inverted_index.prognosis | 57, 146 |
| abstract_inverted_index.reporter, | 85 |
| abstract_inverted_index.viability | 169 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Expression | 32 |
| abstract_inverted_index.Objectives | 3 |
| abstract_inverted_index.associated | 115 |
| abstract_inverted_index.expression | 24, 50, 94, 139, 178 |
| abstract_inverted_index.identified | 153 |
| abstract_inverted_index.luciferase | 84 |
| abstract_inverted_index.prognostic | 193 |
| abstract_inverted_index.recurrence | 197 |
| abstract_inverted_index.regression | 67 |
| abstract_inverted_index.regulating | 212 |
| abstract_inverted_index.survivals. | 136 |
| abstract_inverted_index.underlying | 29 |
| abstract_inverted_index.Conclusions | 186 |
| abstract_inverted_index.independent | 142 |
| abstract_inverted_index.investigate | 18 |
| abstract_inverted_index.mechanisms. | 30 |
| abstract_inverted_index.real‐time | 43 |
| abstract_inverted_index.Associations | 47 |
| abstract_inverted_index.Chi‐square | 61 |
| abstract_inverted_index.Importantly, | 137 |
| abstract_inverted_index.investigated | 82 |
| abstract_inverted_index.noncancerous | 103 |
| abstract_inverted_index.proportional | 66 |
| abstract_inverted_index.quantitative | 42 |
| abstract_inverted_index.significance | 21 |
| abstract_inverted_index.upregulation | 112, 166 |
| abstract_inverted_index.Functionally, | 164 |
| abstract_inverted_index.respectively. | 69 |
| abstract_inverted_index.significantly | 114 |
| abstract_inverted_index.transcription | 45 |
| abstract_inverted_index.hepatocellular | 9 |
| abstract_inverted_index.Kaplan‐Meier, | 63 |
| abstract_inverted_index.miR‐106b‐5p | 23, 35, 49, 74, 93, 111, 138, 160, 165, 184, 187, 203 |
| abstract_inverted_index.overexpression. | 185 |
| abstract_inverted_index.recurrence‐free | 125 |
| abstract_inverted_index.clinicopathological | 53 |
| abstract_inverted_index.microRNA(miR)‐106b‐5p | 7 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 94 |
| corresponding_author_ids | https://openalex.org/A5100735096, https://openalex.org/A5005544676 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 8 |
| corresponding_institution_ids | https://openalex.org/I154093214 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/1 |
| sustainable_development_goals[0].score | 0.6200000047683716 |
| sustainable_development_goals[0].display_name | No poverty |
| citation_normalized_percentile.value | 0.87152352 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |